ArticleCancer chemotherapy and pharmacology2009

A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state.

C L O'Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.